CALLAN JMB INC. 8-K

What Happened
CALLAN JMB Inc. (ticker: CJMB) filed an 8-K on April 10, 2026 reporting it received a deficiency Notice from the Nasdaq Listing Qualifications Department that it does not meet Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 in stockholders’ equity. The company said it will submit a plan to Nasdaq to regain compliance within the initial 45‑day period (by May 22, 2026). If Nasdaq accepts the plan, the exchange may grant up to 180 calendar days from the Notice date (until October 4, 2026) for the company to cure the deficiency. The Notice does not affect the current listing or trading of CJMB common stock.

Key Details

• Nasdaq rule cited: Listing Rule 5550(b)(1) — $2,500,000 minimum stockholders’ equity requirement.
• Deadline to submit compliance plan: 45 days from Notice, until May 22, 2026.
• Potential cure period if plan accepted: up to 180 days from Notice, until October 4, 2026.
• Trading status: No immediate effect; common stock continues to trade under the symbol “CJMB.”

Why It Matters
A Nasdaq deficiency notice signals the company currently lacks the minimum equity required for continued listing, which could lead to delisting if not cured. For investors, the immediate impact is limited — shares continue to trade — but the outcome depends on Nasdaq’s acceptance of CJMB’s compliance plan and the company’s ability to restore required equity within the allowed timeframe. The company also cautioned that forward-looking statements about regaining compliance are subject to risks and uncertainties.